Dear subscriber,

This has been an epic week for BioHarvest Sciences Inc., highlighted by our Dec 8 announcement that we have produced over 10kg of high-density trichome/cannabis biomass WITHOUT GROWING THE PLANT.  This news has caused a groundswell of media and investor attention, and we want to keep you “up-to-speed” on all the action. How productive has this past week been? Our last newsletter was sent on November 30, and these are the new activities that have happened in the past 10 days! Plenty more to come in December, so stay tuned!

Special Request from Ilan Sobel to our BHSC community

Links to “Cannabis Without the Plant – History in the Making” on Social media:  Youtube     Twitter     Facebook     LinkedIn


Dec 8-9 Media highlights

Our public relations teams at Boldt and Thunder11 have been actively introducing the BioHarvest story to journalists, and we are building serious momentum in both the cannabis industry and mainstream media. The following are some coverage highlights from just the past 2 days!

Producing Cannabis Biomass Without Growing A Cannabis Plant: How One Company is Doing It”. Being covered by Forbes.com is a powerful validation that history is truly being made by our R+D team. The article states that our ability to grow cannabis without the plant “Sounds like something out of a science fiction movie, but it’s very real.”  Read Article



THE cannabis magazine shared our Biomass video with their 2.7 Million followers on Dec 9. One day later, their followers have now watched it over 40,000x, and it has 3200+ “likes”. As we become a more prominent member of the cannabis community, we look forward to educating the established cannabis ecosystem on the unique benefits of our products.




CannabisFN.com posted an article on our Biomass release and shared on social media. Their Twitter feed alone has generated more than 20,000 views of the video since Tuesday morning.




On December 8, Ilan presented at the Global Cannabis Summit, an industry conference for leaders in cannabis cultivation, products, science, and investment. We updated our corporate deck to correspond with this event, and you are invited to download the new presentation deck.





New Frontiers
On December 1, we were thrilled to announce that Chris Hadfield, former Commander of the International Space Station, has joined the BioHarvest Sciences Advisory Board. Colonel Hadfield’s mandate is twofold – to act as a technology advisor, and to work with the BioHarvest team on ways to leverage our biotech technology platform to provide essential nutrition and active ingredients for space exploration and potential new

settlements in space. If you have not seen Commander Hadfield’s videos from the space station, look them up on Youtube, as they are amazing!






New to BioHarvest?

All interested investors and media are invited to attend our next “Introduction to BioHarvest” online event on Dec 21. CEO Ilan Sobel will provide an investor-focused introduction to our Science and our Vision, and we will include a live question and answer session. Register now!


BioHarvest Sciences Inc.
Ilan Sobel, Chief Executive Officer

For further information, please contact:

Dave Ryan, VP Investor Relations & Director
Phone: 1 (604) 622-1186
Email: dave@bioharvest.com


Forward-Looking Statements 

Information set forth in this news release includes forward-looking statements that are based on management’s current estimates, beliefs, intentions, and expectations, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. There is no assurance that strong sales metrics experienced to date will result in future demand or that proposed additional marketing expenditures will result in increased sales. Markets for nutraceuticals are unpredictable and subject to changes in consumer tastes and trends as well as economic factors beyond our control.  Delays and cost overruns may result in delays achieving our objectives obtaining market acceptance, and regulatory approvals for geographic expansion is subject to risk and cannot be guaranteed. There is no assurance that the Company sales revenue for 2022 will reach USD 5 to 7 million and there is no assurance that the Company cash flow breaking point will be achieved in 2023. There is no assurance of commercial availability of our Cannabis product in 2022 or that the Company achieves the conversion of the two tons VINIA® facility to Cannabis production in 2022. These things are subject to construction and approval delays and uncertainties that may be beyond the control of BioHarvest. Projected sales of Cannabis will require the Company to obtain production and/or export licensing which cannot be assured.

All forward-looking statements are inherently uncertain and actual results may be affected by a number of material factors beyond our control. Readers should not place undue reliance on forward-looking statements. BHSC does not intend to update forward-looking statement disclosures other than through our regular management discussion and analysis disclosures. 

Readers are cautioned that revenue alone do not give an accurate picture of the financial position of the Company and should be read in the context of the Company’s annual and quarterly financial statements.

Neither the Canadian Securities Exchange nor its Regulation Services Provider accept responsibility for the adequacy or accuracy of this release.